UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934*
(Amendment No. 1)
Altus Pharmaceuticals, Inc.
---------------------------
(Name of Issuer)
Common Stock, par value $0.01 per share
---------------------------------------
(Title of Class of Securities)
02216N105
---------
(CUSIP Number)
July 22, 2009
-------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
--------------------- -------------------------
CUSIP No. 02216N105 13G Page 2 of 8 Pages
----------- ---- -----
--------------------- -------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Warburg Pincus Private Equity VIII, L.P.
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 955,624
OWNED BY ------ ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH ------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
955,624
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,624
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.00%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
PN
---------- ---------------------------------------------------------------------
--------------------- -------------------------
CUSIP No. 02216N105 13G Page 3 of 8 Pages
----------- ---- -----
--------------------- -------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Warburg Pincus & Co.
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 955,624
OWNED BY ------ ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH ------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
955,624
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,624
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.00%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
PN
---------- ---------------------------------------------------------------------
--------------------- -------------------------
CUSIP No. 02216N105 13G Page 4 of 8 Pages
----------- ---- -----
--------------------- -------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Warburg Pincus LLC
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 955,624
OWNED BY ------ ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH ------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
955,624
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,624
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.00%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
OO
---------- ---------------------------------------------------------------------
--------------------- -------------------------
CUSIP No. 02216N105 13G Page 5 of 8 Pages
----------- ---- -----
--------------------- -------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Warburg Pincus Partners LLC
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 955,624
OWNED BY ------ ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH ------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
955,624
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,624
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.00%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
OO
---------- ---------------------------------------------------------------------
--------------------- -------------------------
CUSIP No. 02216N105 13G Page 6 of 8 Pages
----------- ---- -----
--------------------- -------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Charles R. Kaye
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 955,624
OWNED BY ------ ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH ------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
955,624
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,624
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.00%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
---------- ---------------------------------------------------------------------
--------------------- -------------------------
CUSIP No. 02216N105 13G Page 7 of 8 Pages
----------- ---- -----
--------------------- -------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Joseph P. Landy
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 955,624
OWNED BY ------ ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH ------ ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
955,624
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,624
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.00%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
---------- ---------------------------------------------------------------------
This Amendment No. 1 to Schedule 13G (this "Amendment No. 1") is being
filed with respect to the common stock, par value $0.01 per share (the "Common
Stock"), of Altus Pharmaceuticals, Inc., a corporation organized under the laws
of the State of Delaware (the "Company"), to amend the Schedule 13G filed on May
18, 2007 (the "Schedule 13G"). This Amendment No. 1 is being filed on behalf of
Warburg Pincus Private Equity VIII, L.P., a Delaware limited partnership,
Warburg Pincus & Co., a New York general partnership, Warburg Pincus LLC, a New
York limited liability company, Warburg Pincus Partners, LLC, a New York limited
liability company, Charles R. Kaye and Joseph P. Landy (collectively, the
"Warburg Pincus Reporting Persons") to disclose that the Warburg Pincus
Reporting Persons no longer beneficially own more than 5% of the Common Stock.
Capitalized terms used herein and not otherwise defined have the meanings
ascribed to them in the Schedule 13G.
Item 4: Ownership:
------ ----------
The information required by Items 4(a) - (c) is set forth in Rows 4-11 of
the cover page hereto for each Warburg Pincus Reporting Person and is
incorporated herein by reference for each such Warburg Pincus Reporting Person.
The ownership percentages set forth in Rows 4-11 of the cover page are
calculated based on 31,131,056 shares of Common Stock issued and outstanding as
of June 15, 2009, as reported in the Company's Registration Statement on Form
S-3 filed with the U.S. Securities and Exchange Commission on June 23, 2009.
Item 5: Ownership of Five Percent or Less of a Class:
------ --------------------------------------------
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following: [X]
Item 10: Certification:
------- -------------
Each of the Warburg Pincus Reporting Persons hereby makes the following
certification:
By signing below, the undersigned certifies that, to the best of its
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or
effect.
[Signatures on following page]
8
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: July 24, 2009 WARBURG PINCUS PRIVATE EQUITY VIII, L.P.
By: Warburg Pincus Partners, LLC,
its General Partner
By: Warburg Pincus & Co.,
its Managing Member
By: /s/ Scott A. Arenare
----------------------------------------
Name: Scott A. Arenare
Title: Partner
Dated: July 24, 2009 WARBURG PINCUS PARTNERS, LLC
By: Warburg Pincus & Co.,
its Managing Member
By: /s/ Scott A. Arenare
----------------------------------------
Name: Scott A. Arenare
Title: Partner
Dated: July 24, 2009 WARBURG PINCUS LLC
By: /s/ Scott A. Arenare
----------------------------------------
Name: Scott A. Arenare
Title: Member
Dated: July 24, 2009 WARBURG PINCUS & CO.
By: /s/ Scott A. Arenare
----------------------------------------
Name: Scott A. Arenare
Title: Partner
Dated: July 24, 2009
By: /s/ Scott A. Arenare
----------------------------------------
Name: Charles R. Kaye
By: Scott A. Arenare, Attorney-in-Fact*
Dated: July 24, 2009
By: /s/ Scott A. Arenare
-----------------------------------------
Name: Joseph P. Landy
By: Scott A. Arenare, Attorney-in-Fact**
* Power of Attorney given by Mr. Kaye was previously filed with the SEC on March
2, 2006 as an exhibit to a Schedule 13D filed by Building Products, LLC with
respect to Builders FirstSource, Inc.
** Power of Attorney given by Mr. Landy was previously filed with the SEC on
March 2, 2006 as an exhibit to a Schedule 13D filed by Building Products, LLC
with respect to Builders FirstSource, Inc.